by Vora Corporate Finance | Jul 8, 2024 | Insights, Private Equity & IPO
Transaction: Morgan Stanley PE fund, invested INR 500 Crores for a minority stake of 23% stake in Hyderabad Institute of Oncology Private Limited (Omega Hospitals), valuing the hospital chain at more than Rs. 2100 Crores. It will support the ambitious plan of Omega...
by Vora Corporate Finance | Jul 8, 2024 | Insights, Merger & Acquisitions
Transaction: Adani owned Ambuja Cements Limited enters into binding agreement for the acquisition of Hyderabad-based Penna Cement Industries Limited (PCIL) at an EV of Rs. 10,422 Crore. Ambuja will acquire 100% shares of PCIL from its existing promoter group P Pratap...
by Vora Corporate Finance | Jul 8, 2024 | Insights
Secondary Market: The BSE Sensex closed at 79,033 up by 6.86% and the Nifty 50 closed at 24,011 up by 6.57% in June 2024 thriving the Indian stock market on a record-setting spree driven by positive sentiment, with RBI projecting 7.2% growth and strong 5G auction...
by Vora Corporate Finance | Jul 4, 2024 | Insights, Private Equity & IPO
Transaction: Quadria Capital, one of Asia’s largest healthcare-focused private equity firm invested INR 850 Crores in a series F funding round of NephroPlus, valuing the company at more than Rs. 2000 Crores. Through this transaction, Quadria acquires significant...
by Vora Corporate Finance | Jul 4, 2024 | Insights, Merger & Acquisitions
Transaction: Arpwood Partners has entered into an agreement to acquire majority stake in Sitara for infusion of equity capital of Rs. 680 crores for financing its business growth. The existing investors including Investors including Abler Nordic, Oikocredit, RNT...
